Page last updated: 2024-08-21

benzofuran and Parkinson Disease

benzofuran has been researched along with Parkinson Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Olotu, FA; Soliman, MES; Soremekun, OS; Subair, TI1
Ai, N; Chong, CM; Hoi, PM; Hou, T; Lee, SM; Li, CW; Li, S; Liang, W; Pan, P; Shen, M; Yu, H; Zhang, LQ; Zhou, ZY1

Other Studies

2 other study(ies) available for benzofuran and Parkinson Disease

ArticleYear
Therapeutic Path to Double Knockout: Investigating the Selective Dual-Inhibitory Mechanisms of Adenosine Receptors A1 and A2 by a Novel Methoxy-Substituted Benzofuran Derivative in the Treatment of Parkinson's Disease.
    Cell biochemistry and biophysics, 2021, Volume: 79, Issue:1

    Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Antiparkinson Agents; Benzofurans; Catalytic Domain; Computer Simulation; Drug Design; Humans; Ligands; Molecular Conformation; Parkinson Disease; Principal Component Analysis; Protein Binding; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Purinergic P1; Structure-Activity Relationship; Thermodynamics

2021
Discovery of a benzofuran derivative (MBPTA) as a novel ROCK inhibitor that protects against MPP⁺-induced oxidative stress and cell death in SH-SY5Y cells.
    Free radical biology & medicine, 2014, Volume: 74

    Topics: Acetamides; Alkanesulfonic Acids; Antioxidants; Benzofurans; Cell Death; Cell Line, Tumor; Cytoprotection; Drug Discovery; Humans; Membrane Potential, Mitochondrial; Molecular Targeted Therapy; Oncogene Protein v-akt; Oxidants; Oxidative Stress; Parkinson Disease; Phosphatidylinositol 3-Kinases; Pyridinium Compounds; rho-Associated Kinases; Signal Transduction; Thiadiazoles

2014